Skip to main content

Table 3 Top 15 therapeutic classes (by ATC category, level2) by pregnancy risk category and generic name ordered by descending number of dispensings (ND)

From: Use of prescription medicines in Australian women of child-bearing age

Therapeutic group

Category A

Category B1

Category B2

Category B3

Category C

Category D

Psycho-analeptics (NW : 42095) (ND : 245976)

 

Reboxetine (0.6 %)

Desvenlafaxine (16.2 %)

Duloxetine (9.5 %)

Sertraline (14.2 %)

Paroxetine (3.1 %) (N = 6574 dispenses)

Venlafaxine (13.3 %)

Mirtazapine (6.4 %)

Escitalopram (14.0 %)

 

Methylphenidate (1.3 %)

Dexamphetamine (1.1 %)

Fluoxetine (8.8 %)

 
 

Moclobemide (0.3 %)

Amitriptyline (7.0 %)

 
  

Citalopram (5.5 %)

 
  

Fluvoxamine (2.0 %)

 
  

Dothiepin (0.7 %)

 
  

Doxepin (0.4 %)

 
  

Clomipramine (0.3 %)

 
  

Nortriptyline (0.3 %)

 
  

Imipramine (0.2 %)

 

Anti-bacterials for systemic use (NW: 106522) (ND: 178481)

Amoxycillin (26.0 %)

Amoxycillin with Clavulanic acid (17.0 %)

Dicloxacillin (1.5 %)

Trimethoprim (5.5 %)

Trimethoprim with sulphamethoxazole (1.4 %)

Doxycycline (6.4 %) (N = 12651)

Cefalexin (22.5 %)

Roxithromycin (8.4 %)

Clarithromycin (4.0 %)

Minocycline (1.3 %) (N = 3103)

Phenoxymethylpenicillin (5.1 %)

Flucloxacillin (3.6 %)

 

Ciprofloxacin (0.3 %)

  

Erythromycin (4.2 %)

Cefaclor (2.5 %)

 

Norfloxacin (0.3 %)

  

Clindamycin (1.2 %)

Azithromycin (1.9 %)

    

Nitrofurantoin (0.5 %)

Cefuroxime (0.4 %)

    

Hexamine (0.3 %)

     

Analgesics (NW: 31705) (ND: 115460)

Codeine with paracetamol (53.2 %)

Rizatriptan (2.3 %)

 

Sumatriptan (3.3 %)

Oxycodone (17.5 %)

 

Paracetamol (11.1 %)

Pizotifen (1.9 %)

 

Zolmitriptan (0.4 %)

Tramadol (13.5 %)

 
 

Eletriptan (1.1 %)

 

Naratriptan (0.3 %)

Oxycodone comb. (2.3 %)

 
    

Buprenorphine (1.7 %)

 
    

Fentanyl (1.1 %)

 
    

Morphine (0.8 %)

 
    

Hydromorphone (0.4 %)

 

Psycholeptics (NW: 20157) (ND:111528)

    

Diazepam (37.2 %)

Lithium (3.0 %) (N = 1978)

    

Quetiapine (19.8 %)

 
    

Temazepam (22.2 %)

 
    

Prochlorperazine (15.7 %)

 
    

Olanzapine (8.0 %)

 
    

Oxazepam (7.3 %)

 
    

Alprazolam (4.9 %)

 
    

Risperidone (3.6 %)

 
    

Aripiprazole (3.3 %)

 
    

Nitrazepam (2.1 %)

 
    

Paliperidone (1.5 %)

 
    

Chlorpromazine (1.1 %)

 
     

Asenapine (1.0 %)

 
     

Amisulpride (0.9 %)

 
     

Ziprasidone (0.9 %)

 
     

Pericyazine (0.9 %)

 
     

Clozapine (0.7 %)

 
     

Zuclopenthixol (0.5 %)

 

Drugs for obstructive airway diseases (NW: 34757) (ND: 88275)

Salbutamol (30.9 %)

Tiotropium (1.1 %)

 

Fluticasone with salmeterol (33.9 %)

  

Budesonide (2.1 %)

Ipratropium (1.1 %)

 

Budesonide with eformoterol (26.0 %)

  

Terbutaline (1.4 %)

Nedocromil (1.1 %)

 

Fluticasone (4.2 %)

  
   

Ciclesonide (1.0 %)

  

Sex hormones and modulators of the genital system (NW: 46830) (ND: 84543)

Medroxyprogesterone (10.9 %)a

Oestradiol (0.9 %) (estrogen)

 

Levonorgestrel with ethinyloestradiol (56.3 %)a

 

Norethisterone (3.4 %) (N = 3504)b

   

Etonogestrel (19.3 %)a

 

Medroxyprogesterone (1.1 %) (N = 1001)b

   

Norethisterone with ethinyloestradiol (5.5 %)a

  
   

Levonorgestrel (4.4 %)a

  
   

Norethisterone (1.1 %)a

  
   

Clomiphene (0.6 %) (ovulation stimulant)

  

Drugs for acid-related disorders (NW: 19444) (ND: 59365)

 

Rabeprazole (9.8 %)

 

Esomeprazole (56.4 %)

  
 

Ranitidine (7.2 %)

 

Pantoprazole (16.4 %)

  
   

Esomeprazole and amoxicilan and clarithromycin (9.2 %)

  
   

Omeprazole (6.6 %)

  
   

Lansoprazole (1.2 %)

  
   

Nizatidine (0.7 %)

  

Antiepileptics (NW: 7784) (ND: 46092)

 

Gabapentin (1.9 %)

 

Pregabalin (29.0 %)

Clonazepam (1.9 %)

Valproate (29.1 %) (N = 8364)

   

Levetiracetam (7.8 %)

 

Topiramate (14.3 %) (N = 7607)

   

Lacosamide (1.0 %)

 

Lamotrigine (11.6 %) (N = 8803

     

Carbamazepine (10.5 %) (N = 3153)

     

Phenytoin (1.3 %) (N = 472)

     

Oxcarbazepine (0.7 %) (N = 410)

Anti-inflammatory products (NW: 14676) (ND: 25747)

   

Celecoxib (13.9 %)

Ibuprofen (23.7 %)

 
    

Diclofenac (21.1 %)

 
    

Meloxicam (20.6 %)

 
    

Naproxen (13.1 %)

 
    

Mefenamic acid (10.6 %)

 
    

Indomethacin (3.9 %)

 
    

Piroxicam (1.5 %)

 

Corticosteroids, dermatological preparations (NW: 14759) (ND: 23389)

Mometasone (37.7 %)

     

Betamethasone (34.7 %)

     

Methylprednisolone (21.3 %)

     

Hydrocortisone (13.4 %)

     

Triamcinolone (8.4 %)

     

Drugs used in diabetes (NW: 6792) (ND: 21668)

Insulin aspart (23.8 %)

  

Insulin glargine (16.0 %)

Metformin (40.4 %)

 

Insulin (human) (8.7 %)

  

Sitagliptin (1.8 %)

Gliclazide (5.5 %)

 

Insulin lispro (5.7 %)

   

Metformin with sitagliptin (3.0 %)

 

Insulin detemir (5.6 %)

   

Exenatide (1.9 %)

 

Insulin aspart/protamine (3.3 %)

   

Metformin with vildagliptin (1.4 %)

 

Lipid modifying agents (NW: 3842) (ND: 20916)

   

Fenofibrate (5.6 %)

 

Rosuvastatin (45.3 %) (N = 9225)

   

Ezetimibe (3.7 %)

 

Atorvastatin (39.3 %) (N-7760)

     

Simvastatin (4.0 %) (N = 750)

     

Simvastatin and ezetimibe (3.1 %) (N = 680)

     

Atorvastatin and amlodipine (2.3 %) (N = 544)

Agents acting on renin-angiotensin system (NW: 3560) (ND: 19330)

     

Perindopril (29.7 %) (N = 5191)

     

Candesartan (12.8 %) (N = 2154)

     

Irbesartan (12.2 %) (N = 2349)

     

Telmisartan (12.1 %) (N = 2183)

     

Ramipril (10.6 %) (N = 2030)

     

Perindopril and amlodipine (7.4 %) (N = 1412)

     

Olmesartan (5.8 %) (N = 949)

     

Irbesartan with hydrochlorothiazide (HCTZ) (5.1 %) (N = 866)

     

Perindopril with indapamide (4.4 %) (N = 789)

     

Telmisartan with HCTZ (4.2 %) (N = 722)

     

Candesartan with HCTZ (4.2 %) (N = 685)

Antivirals for systemic use (NW: 6837) (ND: 16556)

 

Famciclovir (32.6 %)

 

Valaciclovir (60.2 %)

  
   

Aciclovir (8.1 %)

  

Drugs for gastrointestinal disorders (NW: 8874) (ND: 13074)

Metoclopramide (88.6 %)

 

Domperidone (11.4 %)

   
  1. The % reported for each medicine is from the number of unique women (NW) receiving the given therapeutic group. If the percentages of unique women sum up to over 100 it denotes that some women received multiple medicines from the same therapeutic class in 2013. For medicines in pregnancy risk category D we also reported the number of dispenses
  2. ahormonal contraceptives for systemic use (ATC G03A); b progestogens (ATC G03D)